224 related articles for article (PubMed ID: 1321859)
1. Immune response of elderly individuals to a live attenuated varicella vaccine.
Levin MJ; Murray M; Rotbart HA; Zerbe GO; White CJ; Hayward AR
J Infect Dis; 1992 Aug; 166(2):253-9. PubMed ID: 1321859
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
[TBL] [Abstract][Full Text] [Related]
3. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults.
Hayward AR; Buda K; Levin MJ
Viral Immunol; 1994; 7(1):31-6. PubMed ID: 7986334
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older.
Levine MJ; Ellison MC; Zerbe GO; Barber D; Chan C; Stinson D; Jones M; Hayward AR
Vaccine; 2000 Jun; 18(25):2915-20. PubMed ID: 10812235
[TBL] [Abstract][Full Text] [Related]
5. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine.
Levin MJ; Murray M; Zerbe GO; White CJ; Hayward AR
J Infect Dis; 1994 Sep; 170(3):522-6. PubMed ID: 8077709
[TBL] [Abstract][Full Text] [Related]
6. Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Infect Dis; 1988 Dec; 158(6):1245-52. PubMed ID: 2848901
[TBL] [Abstract][Full Text] [Related]
7. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
[TBL] [Abstract][Full Text] [Related]
8. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.
Levin MJ; Barber D; Goldblatt E; Jones M; LaFleur B; Chan C; Stinson D; Zerbe GO; Hayward AR
J Infect Dis; 1998 Nov; 178 Suppl 1():S109-12. PubMed ID: 9852987
[TBL] [Abstract][Full Text] [Related]
9. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.
Levin MJ; Smith JG; Kaufhold RM; Barber D; Hayward AR; Chan CY; Chan IS; Li DJ; Wang W; Keller PM; Shaw A; Silber JL; Schlienger K; Chalikonda I; Vessey SJ; Caulfield MJ
J Infect Dis; 2003 Nov; 188(9):1336-44. PubMed ID: 14593591
[TBL] [Abstract][Full Text] [Related]
10. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
11. Safety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunization.
Watson B; Rothstein E; Bernstein H; Arbeter A; Arvin A; Chartrand S; Clements D; Kumar ML; Reisinger K; Blatter M
J Infect Dis; 1995 Jul; 172(1):217-9. PubMed ID: 7797914
[TBL] [Abstract][Full Text] [Related]
12. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.
Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372
[TBL] [Abstract][Full Text] [Related]
13. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
15. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
Nader S; Bergen R; Sharp M; Arvin AM
J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
[TBL] [Abstract][Full Text] [Related]
17. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
Levin MJ; Oxman MN; Zhang JH; Johnson GR; Stanley H; Hayward AR; Caulfield MJ; Irwin MR; Smith JG; Clair J; Chan IS; Williams H; Harbecke R; Marchese R; Straus SE; Gershon A; Weinberg A;
J Infect Dis; 2008 Mar; 197(6):825-35. PubMed ID: 18419349
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity to varicella-zoster virus.
Arvin AM
J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
[TBL] [Abstract][Full Text] [Related]
20. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
